Home > Healthcare > Medical Services > Cell & Gene Therapy Clinical Trial Services Market

Cell & Gene Therapy Clinical Trial Services Market Share

Report ID: GMI9355
Published Date: May 2024
Report Format: PDF

Download Free Sample

Cell and Gene Therapy Clinical Trial Services Market Share

The competitive landscape of the market is characterized by the presence of established pharmaceutical & biotechnology companies along with CROs that collaborates to provide cell and gene therapy clinical trial services vying for market share. Key players are engaging in strategic initiatives such as collaboration, investment, and partnerships to strengthen their service portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for cell and gene therapy clinical trial services.

Cell and Gene Therapy Clinical Trial Services Market Companies

Prominent players operating in the cell and gene therapy clinical trial services industry are as mentioned below:

ADVARRA
Charles River Laboratories International Inc.
Catalent Pharma
ICON PLC
IQVIA
Medpace, Inc.
Novotech
Precision Medicine Group, LLC
Parexel International
Syneos Health
Sharp Services, LLC
Thermo Fisher Scientific Inc.
Worldwide Clinical Trials

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The cell and gene therapy clinical trial services market was valued at USD 4 billion in 2023 and will record 10.8% CAGR from 2024-2032, owing to the growing prevalence of chronic and genetic diseases.

The cell therapy segment in the market is expected to reach USD 4.2 billion by end of 2032, due to the improvements in cell manufacturing techniques, such as automation and scale-up capabilities.

U.S. cell & gene therapy clinical trial services market size is expected to exhibit 11% CAGR between 2024

ADVARRA, Charles River Laboratories International Inc., Catalent Pharma, ICON PLC, IQVIA, Medpace, Inc., Novotech, Precision Medicine Group, LLC, Parexel International, Syneos Health, Sharp Services, LLC, Thermo Fisher Scientific Inc. and Worldwide Clinical Trials